10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      “I need to know what makes somebody tick …”: Challenges and Strategies of Implementing Shared Decision‐Making in Individualized Oncology

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Although shared decision making is advocated in most fields of medicine, implementation in oncology is challenging. Considering the importance of patient involvement in the era of individualized oncology, this article analyzes barriers to shared decision making.

          Abstract

          Background.

          Shared decision‐making (SDM) has been advocated as an ethical framework for decision‐making in cancer care. According to SDM, patients make decisions in light of their values and based on the available evidence. However, SDM is difficult to implement in cancer care. A lack of applicability in practice is often reported. This empirical‐ethical study explores factors potentially relevant to current difficulties in translating the concept of SDM into clinical practice.

          Methods.

          This study was conducted with nonparticipant observation of the decision‐making process in patients with gastrointestinal cancers for whom the benefit of adjuvant chemotherapy was uncertain according to clinical guidelines. Triangulation of qualitative data analysis was conducted by means of semistructured interviews subsequent to the observation. Observation notes and interview transcripts were analyzed according to the principles of grounded theory.

          Results.

          Deviating from the concept of SDM, oncologists initiated a process of eliciting values and medical information prior to conveying information. The purpose of this approach was to select and individualize information relevant to the treatment decision. In doing so, the oncologists observed used two strategies: “biographical communication” and a “metacommunicative approach.” Both strategies could be shown to be effective or to fail depending on patients’ characteristics such as their view of the physicians’ role and the relevance of value‐related information for medical decision‐making.

          Conclusion.

          In contrast to the conceptual account of SDM, oncologists are in need of patient‐related information prior to conveying information. Both strategies observed to elicit such information are in principle justifiable but need to be adapted in accordance with patient preferences and decision‐making styles.

          Implications for Practice.

          This study showed that knowledge of patients’ values and preferences is very important to properly adapt the giving of medical information and to further the process of shared decision‐making. Shared decision‐making (SDM) trainings should consider different strategies of talking about values. The right strategy depends largely on the patient's preferences in communication. To be aware of the role of values in SDM and to be able to switch communicative strategies might prove to be of particular value. A more systematic evaluation of the patient's decision‐making preferences as part of routine procedures in hospitals might help to reduce value‐related barriers in communication.

          Related collections

          Author and article information

          Contributors
          joschka.haltaufderheide@rub.de
          Journal
          Oncologist
          Oncologist
          10.1002/(ISSN)1549-490X
          The Oncologist
          oncologist
          theoncologist
          The Oncologist
          John Wiley & Sons, Inc. (Hoboken, USA )
          1083-7159
          1549-490X
          06 September 2018
          April 2019
          : 24
          : 4 ( doiID: 10.1002/onco.v24.4 )
          : 555-562
          Affiliations
          [ a ] Department for Medical Ethics and History of Medicine, Ruhr‐University , Bochum, Germany
          [ b ] Department of Hematology, Oncology and Palliative Care, St. Josef‐Hospital, Ruhr‐University , Bochum, Germany
          [ c ] Institute of Biomedical Ethics and History of Medicine, University of Zurich , Switzerland
          [ d ] Institute for History and Ethics of Medicine, Martin Luther University , Halle‐Wittengerg, Germany
          Author notes

          Disclosures of potential conflicts of interest may be found at the end of this article.

          [*] [* ]Correspondence: Joschka Haltaufderheide, Ph.D., M.A., Ruhr University Bochum, Department for Medical Ethics and History of Medicine, Markstrass 158a, 44799 Bochum, Germany. Telephone: 49‐234‐32‐28573; joschka.haltaufderheide@ 123456rub.de
          Article
          PMC6459243 PMC6459243 6459243 ONCO12676
          10.1634/theoncologist.2017-0615
          6459243
          30190300
          4bf9dbd0-9b06-4d55-985a-795abc03abf7
          © AlphaMed Press 2018
          History
          : 22 November 2017
          : 06 July 2018
          Page count
          Pages: 8
          Funding
          Funded by: Georgius Agricola Stiftung Ruhr;
          Categories
          6
          35
          Medical Ethics

          Chemotherapy,Decision‐making,Ethics,Uncertainty,Shared decision‐making

          Comments

          Comment on this article